Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Overcoming adherence issues and other barriers to optimal care in gout

Overcoming adherence issues and other barriers to optimal care in gout REVIEW URRENT Overcoming adherence issues and other barriers to PINION optimal care in gout Navine Nasser-Ghodsi and Leslie R. Harrold Purpose of review This review presents research published over the last year examining use of urate-lowering therapy (ULT) as well as trends over time in adherence to this class of agents. Additionally, it explores factors associated with nonadherence to ULTs for chronic gout and interventions to improve chronic gout management. Recent findings New literature suggests prescriptions of ULTs for prevalent and incident gout patients remains lower than expected based on the burden of the disease in the population. Overall ULT adherence remains suboptimal, in part related to inadequate patient education and copayment costs; although one study demonstrated improvement in adherence over a 15-year study period. Finally, interventions that include patient education and medication titration based on laboratory results successfully lowered serum urate levels to less than 6 mg/dl in the majority of patients. Summary Gout remains a prevalent disease that is poorly managed despite effective treatments. Recent research suggests that ULTs are underutilized and even when prescribed are not well adhered to. Patient-centered interventions that focus on education about pharmacologic therapy and lifestyle modifications with medication titration have resulted http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in Rheumatology Wolters Kluwer Health

Overcoming adherence issues and other barriers to optimal care in gout

Harrold, Leslie R.
Current Opinion in Rheumatology , Volume 27 (2) – Mar 1, 2015
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/overcoming-adherence-issues-and-other-barriers-to-optimal-care-in-gout-IFiHAGYxSG

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1040-8711
eISSN
1531-6963
DOI
10.1097/BOR.0000000000000141
pmid
25633242
Publisher site
See Article on Publisher Site

Abstract

REVIEW URRENT Overcoming adherence issues and other barriers to PINION optimal care in gout Navine Nasser-Ghodsi and Leslie R. Harrold Purpose of review This review presents research published over the last year examining use of urate-lowering therapy (ULT) as well as trends over time in adherence to this class of agents. Additionally, it explores factors associated with nonadherence to ULTs for chronic gout and interventions to improve chronic gout management. Recent findings New literature suggests prescriptions of ULTs for prevalent and incident gout patients remains lower than expected based on the burden of the disease in the population. Overall ULT adherence remains suboptimal, in part related to inadequate patient education and copayment costs; although one study demonstrated improvement in adherence over a 15-year study period. Finally, interventions that include patient education and medication titration based on laboratory results successfully lowered serum urate levels to less than 6 mg/dl in the majority of patients. Summary Gout remains a prevalent disease that is poorly managed despite effective treatments. Recent research suggests that ULTs are underutilized and even when prescribed are not well adhered to. Patient-centered interventions that focus on education about pharmacologic therapy and lifestyle modifications with medication titration have resulted

Journal

Current Opinion in Rheumatology – Wolters Kluwer Health

Published: Mar 1, 2015

There are no references for this article.